Surgery Partners exec trades stock, gets RSAs

Q: What insider transactions did Surgery Partners (SGRY) executive William Trenton Webb report?

William Trenton Webb reported both sales and awards of Surgery Partners (SGRY) common stock. He sold shares in open-market transactions for tax withholding and received new restricted stock awards that vest over one and two years from the March 5, 2026 grant date.

Q: How many Surgery Partners (SGRY) shares did William Trenton Webb sell and at what prices?

William Trenton Webb sold 272 Surgery Partners shares at $13.93 on March 6, 2026 and 1,794 shares at $13.86 on March 5, 2026. Footnotes state these sales were made to cover tax withholding obligations from recently vested restricted stock.

Q: What restricted stock awards did William Trenton Webb receive from Surgery Partners (SGRY)?

On March 5, 2026, William Trenton Webb received restricted stock awards of Surgery Partners common stock. One grant vests on the first anniversary of the grant date and another vests on the second anniversary, aligning his compensation with the company’s future performance over multiple years.

Q: What do the weighted average prices in the Surgery Partners (SGRY) Form 4 mean?

The Form 4 notes that reported prices are weighted averages, meaning multiple trades occurred at different prices. The insider undertakes to provide full details of each separate price upon request to the company, any security holder, or the SEC staff, ensuring additional transparency.

Surgery Partners, Inc. American Group President William Trenton Webb reported a mix of stock sales and stock awards.

Filing Impact

(High)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Surgery Partners, Inc. American Group President William Trenton Webb reported a mix of stock sales and stock awards. He sold 272 common shares at $13.93 on March 6, 2026 and 1,794 shares at $13.86 on March 5, 2026 to satisfy tax withholding obligations related to vesting restricted stock.

Following these sales, he directly owned 74,249 common shares. Webb also received restricted stock awards on March 5, 2026, including 20,454 shares vesting on the first anniversary of the grant date and 11,438 shares vesting on the second anniversary.

Insider Trade Summary

Net Seller: 2,066 shares

Net Sell 4 txns

Insider Webb William Trenton

Role American Group President

Sold 2,066 shs ($29K)

Type	Security	Shares	Price	Value
Sale	Common Stock	272	$13.93	$4K
Sale	Common Stock	1,794	$13.86	$25K
Grant/Award	Common Stock	20,454	$14.11	$289K
Grant/Award	Common Stock	11,438	$14.11	$161K

Holdings After Transaction: Common Stock — 74,249 shares (Direct)

Footnotes (5)

F1. Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 2, 2026.
F2. The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3. Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026.
F4. Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.
F5. Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Surgery Partners (SGRY) executive William Trenton Webb report?

William Trenton Webb reported both sales and awards of Surgery Partners (SGRY) common stock. He sold shares in open-market transactions for tax withholding and received new restricted stock awards that vest over one and two years from the March 5, 2026 grant date.

How many Surgery Partners (SGRY) shares did William Trenton Webb sell and at what prices?

William Trenton Webb sold 272 Surgery Partners shares at $13.93 on March 6, 2026 and 1,794 shares at $13.86 on March 5, 2026. Footnotes state these sales were made to cover tax withholding obligations from recently vested restricted stock.

Why did the Surgery Partners (SGRY) executive sell shares in this Form 4 filing?

The filing explains that the reported share sales were to satisfy tax withholding obligations arising from the vesting of earlier restricted stock awards. This means the transactions were not discretionary portfolio trades, but sales executed to cover income tax liabilities tied to equity compensation.

What restricted stock awards did William Trenton Webb receive from Surgery Partners (SGRY)?

On March 5, 2026, William Trenton Webb received restricted stock awards of Surgery Partners common stock. One grant vests on the first anniversary of the grant date and another vests on the second anniversary, aligning his compensation with the company’s future performance over multiple years.

How many Surgery Partners (SGRY) shares does William Trenton Webb own after these transactions?

After the March 6, 2026 sale, William Trenton Webb directly owned 74,249 shares of Surgery Partners common stock. This figure reflects his holdings following the reported open-market tax-related sales and the concurrent restricted stock awards granted on March 5, 2026.

What do the weighted average prices in the Surgery Partners (SGRY) Form 4 mean?

The Form 4 notes that reported prices are weighted averages, meaning multiple trades occurred at different prices. The insider undertakes to provide full details of each separate price upon request to the company, any security holder, or the SEC staff, ensuring additional transparency.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/09/2026 - 07:32 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Webb William Trenton

(Last)

(First)

(Middle)

340 SEVEN SPRINGS WAY, SUITE 600

(Street)

BRENTWOOD

37027

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Surgery Partners, Inc. [ SGRY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	American Group President

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/06/2026		S		272⁽¹⁾	D	$13.93⁽²⁾	74,249	D
Common Stock	03/05/2026		S		1,794⁽³⁾	D	$13.86⁽²⁾	72,455	D
Common Stock	03/05/2026		A		20,454⁽⁴⁾	A	$14.11	92,909	D
Common Stock	03/05/2026		A		11,438⁽⁵⁾	A	$14.11	104,347	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 2, 2026.

2. The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

3. Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026.

4. Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.

5. Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.

Remarks:

	/s/ Jennifer Baldock, Attorney-in-Fact	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR